https://novapharmanews.com/us/news/fda-orphan-drug-inhibikase-ikt-001-pah 2026-07-28T12:56:15.480Z NovaPharmaNews en 2026-07-28T12:56:15.480Z FDA Grants Orphan Drug Nod to IKT-001 for PAH IKT-001, imatinib, Pulmonary Diseases, Rare Diseases https://novapharmanews.com/uploads/articles/fda-orphan-drug-inhibikase-ikt-001-pah.webp FDA Grants Orphan Drug Nod to IKT-001 for PAH https://novapharmanews.com/us/news/fda-accepts-biomarin-voxzogo-snda-full-achondroplasia 2026-07-28T12:56:12.746Z NovaPharmaNews en 2026-07-28T12:56:12.746Z FDA Accepts VOXZOGO sNDA; PDUFA Feb. 28, 2027 VOXZOGO, vosoritide, Rare Diseases, Pediatric Diseases https://novapharmanews.com/uploads/articles/fda-accepts-biomarin-voxzogo-snda-full-achondroplasia.webp FDA Accepts VOXZOGO sNDA; PDUFA Feb. 28, 2027 https://novapharmanews.com/us/news/fda-approves-leqembi-iqlik-initiation-dose-alzheimers 2026-07-28T12:56:10.092Z NovaPharmaNews en 2026-07-28T12:56:10.092Z FDA Approves LEQEMBI IQLIK SC Initiation for Alzheimer LEQEMBI IQLIK, lecanemab-irmb, LEQEMBI, Alzheimer's Disease, Neurology https://novapharmanews.com/uploads/articles/fda-approves-leqembi-iqlik-initiation-dose-alzheimers.webp FDA Approves LEQEMBI IQLIK SC Initiation for Alzheimer https://novapharmanews.com/us/news/fda-fabhalta-traditional-approval-igan-kidney-decline 2026-07-28T12:56:07.433Z NovaPharmaNews en 2026-07-28T12:56:07.433Z FDA Grants Fabhalta Traditional Nod, -48% eGFR Slope Fabhalta, iptacopan, Kidney Disease, Rare Diseases https://novapharmanews.com/uploads/articles/fda-fabhalta-traditional-approval-igan-kidney-decline.webp FDA Grants Fabhalta Traditional Nod, -48% eGFR Slope https://novapharmanews.com/us/news/fda-approves-lytenava-ophthalmic-bevacizumab-wet-amd 2026-07-28T12:56:03.741Z NovaPharmaNews en 2026-07-28T12:56:03.741Z FDA Approves LYTENAVA Ophthalmic Bevacizumab for Wet AMD LYTENAVA, bevacizumab-vikg, ONS-5010, Ophthalmology, Retinal Diseases https://novapharmanews.com/uploads/articles/fda-approves-lytenava-ophthalmic-bevacizumab-wet-amd.webp FDA Approves LYTENAVA Ophthalmic Bevacizumab for Wet AMD